References
- Dupre N, Valdmanis P, Bouchard JP, Rouleau GA. Autosomal dominant primary lateral sclerosis. Neurology. 2007; 68: 1156–7
- Brugman F, Wokke JH, Vianney de Jong JM, Franssen H, Faber CG, van den Berg LH. Primary lateral sclerosis as a phenotypic manifestation of familial ALS. Neurology. 2005; 64: 1778–9
- Appelbaum JS, Roos RP, Salazar-Grueso EF, Buchman A, Iannaccone S, Glantz R, et al. Intrafamilial heterogeneity in hereditary motor neuron disease. Neurology. 1992; 42: 1488–92
- Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain. 1992; 115: 495–520
- Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology. 2006; 66: 647–53
- Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol. 2007; 64: 232–6
- Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A for the ‘Registro Lombardo SLA’ SLALOM. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005; 25: 114–9
- Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994; 330: 585–91
- Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann KT, Nolte CH, et al. Early onset ALS with long-term survival associated with spastin gene mutation. Neurology. 2005; 65: 141–3
- Brugman F, Eymard-Pierre E, van den Berg LH, Wokke JH, Gauthier-Barichard F, Boespflug-Tanguy O. Adult-onset primary lateral sclerosis is not associated with mutations in the ALS2 gene. Neurology. 2007; 69: 702–4